US FDA’s Califf Says Publishing Complete Response Letters Could Help Fight Misinformation
Executive Summary
But the commissioner also said proponents of releasing CRs may be making too much of the idea, because there are few CRs actually issued.
You may also be interested in...
US FDA Commissioner Califf Takes On Misinformation, Starting With ‘Rumor Control’
Agency leader expects to spend about a year developing a strategy to combat misinformation. On 5 August, the agency unveiled what appears to be an early component of the initiative – a web page titled Rumor Control, with facts about the safety and components of COVID-19 vaccines.
US FDA’s 2022 Novel Agent Actions Suggest Acceleration In Use Of Complete Response Letters
COVID does not appear to be a driving factor, and letters are split almost equally between clinical and quality concerns.
Califf Kicks Off Commissionership With Pledge To Counter Misinformation
New FDA commissioner commitment to counter misinformation also appears to include pledge to ensure agency is driven by science-based decisions, not politics.